GSRX Industries Inc, through its subsidiaries, is in the business of acquiring, developing, and operating retail cannabis dispensaries and non-tetrahydrocannabinol (THC) cannabidiol (CBD) retail stores. The Company also is in the process of expanding its business to include distribution, extraction and light manufacturing, and delivery of cannabis and cannabinoid products. It operates five cannabis dispensaries in Puerto Rico under the name Green Spirit RX and one dispensary in California under the name The Green Room. The Company also owns and operates the e-commerce site GetPureAndNatural.com, which offers a broad range of hemp extract products.

Employees

Sector

Pharmaceuticals

More about the company

Market Closed - OTC Markets Other stock markets 09:38:53 2026-05-05 EDT			5-day change	1st Jan Change
0.000100 ^USD	-.--%		-.--%	-

21-02-16	Gsrx Industries Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI
21-01-08	GSRX Industries Inc. Announces Resignation of Aman Parmar as Member of the Board of Directors	CI

Market Cap	4.09M 3.56M 3.29M 3.09M 5.78M 385M 5.82M 39.08M 15.18M 190M 15.35M 15.02M 658M	P/E 2018	-4.29x	P/E 2019	-0.03x
Enterprise Value	6.36M 5.54M 5.11M 4.81M 8.99M 599M 9.05M 60.78M 23.6M 295M 23.87M 23.36M 1.02B	EV / Sales 2018	26,486,381x	EV / Sales 2019	328,290x
Free-Float	13.26%	Yield 2018 *	-	Yield 2019	-

21-02-16	Gsrx Industries Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI
21-01-08	GSRX Industries Inc. Announces Resignation of Aman Parmar as Member of the Board of Directors	CI
20-11-04	Department of Health of Puerto Rico Has Not Renewed Licenses Held by GSRX Industries Inc	CI
20-10-18	Seneca Capital Partners, LP acquired 95% interest in Green Room Palm Springs, LLC from GSRX Industries Inc. for $0.4 million.	CI
20-06-11	Gsrx Industries Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	CI
20-06-10	GSRX Industries Inc. Auditor Raises 'Going Concern' Doubt	CI
20-05-12	Gsrx Industries Inc. Appoints Steven Farkas to Serve as A Director of the Corporation	CI
20-05-08	GSRX Industries Inc. Announces Resignation of Mike Aujla as Member of the Board of Directors	CI
20-05-06	GSRX Industries Inc. Announces Board Changes	CI
20-03-11	GSRX Industries Inc. Announces Management Changes	CI
19-11-19	Gsrx Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
19-10-03	GSRX Industries Inc Announces Resignation of Andrew Alvis as Chief Operating Officer	CI
19-09-23	GSRX Industries Inc. Receives State-Wide Manufacturing and Distribution Licenses for its Facility in Point Arena, California	CI

21-02-16	GSRX INDUSTRIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q)	AQ
21-02-04	GSRX Industries Inc. Announces the Launch of Wrap Hack Cafe, a Virtual Delivery Only Restaurant	NE
21-01-22	GSRX Industries Inc. Announces New Corporate Identity, Expansion of Business Verticals and Relocation of Corporate Headquarters	NE
21-01-08	GSRX INDUSTRIES INC. : Change in Directors or Principal Officers (form 8-K)	AQ
20-11-24	GSRX INDUSTRIES INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ

GSRX Industries Inc. Stock

Stocks

GSRX

US36255V1070

Pharmaceuticals

Valuation: GSRX Industries Inc.

Chart: GSRX Industries Inc.

Latest news : GSRX Industries Inc.

Press Releases: GSRX Industries Inc.

Course Extremes

Managers and Directors: GSRX Industries Inc.

Other Pharmaceuticals

Financials

Company Profile

Manager	Title	Age	Since
Troy Nihart CEO	Chief Executive Officer	48	2020-03-09
Thomas J. Gingerich DFI	Director of Finance/CFO	65	-

Director	Title	Age	Since
Troy Nihart CHM	Chairman	48	2020-03-09
Jeff Rogers BRD	Director/Board Member	63	2020-03-09
Shaun Dale BRD	Director/Board Member	49	2020-04-22

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GSRX INDUSTRIES INC.	-.--%	-.--%	-.--%	-50.00%	8.18K
ELI LILLY AND COMPANY	-1.21%	-5.37%	+39.94%	+145.38%	992B
JOHNSON & JOHNSON	-2.48%	-4.17%	+51.52%	+39.07%	564B
ABBVIE INC.	-2.14%	-3.68%	+16.71%	+56.15%	391B
ROCHE HOLDING AG	-1.18%	+0.25%	+25.86%	+16.53%	330B
ASTRAZENECA PLC	-2.36%	-3.12%	+24.71%	+11.59%	280B
NOVARTIS AG	-2.45%	-2.88%	+24.29%	+30.06%	279B
NOVO NORDISK A/S	-1.91%	-0.87%	-41.95%	-49.25%	196B
AMGEN INC.	-1.19%	-4.65%	+16.56%	+47.00%	184B
GILEAD SCIENCES, INC.	-1.35%	-1.68%	+14.59%	+56.94%	156B
Average	-1.63%	-1.79%	+17.22%	+30.35%	337.12B
Weighted average by Cap.	-1.77%	-2.88%	+28.03%	+63.21%

	2018	2019
Net sales	2.68 2.34 2.15 2.03 3.79 252.72 3.82 25.62 9.95 124.54 10.07 9.85 431.68	11 9.59 8.84 8.31 15.55 1.04K 15.66 105.16 40.84 511.1 41.31 40.42 1.77K
Net income	-16.24M -14.15M -13.04M -12.27M -22.95M -1.53B -23.11M -155M -60.27M -754M -60.95M -59.65M -2.61B	-36.26M -31.59M -29.12M -27.39M -51.24M -3.42B -51.6M -346M -135M -1.68B -136M -133M -5.84B
Net Debt	-1.31M -1.14M -1.06M -992K -1.86M -124M -1.87M -12.55M -4.88M -61.01M -4.93M -4.83M -211M	2.27M 1.98M 1.82M 1.72M 3.21M 214M 3.23M 21.7M 8.43M 105M 8.52M 8.34M 366M

Current year	0		0
1 year	0		0
3 years	0		0.01
5 years	0		0.09
10 years	0		25